What is TB-500?
TB-500 is the name given to a synthetic peptide that copies one short stretch of thymosin beta-4: the seven amino acids Leu-Lys-Lys-Thr-Glu-Thr-Gln (LKKTETQ), positions 17 to 23, with an acetyl group added to the front end.
Thymosin beta-4 itself is a natural 43-amino-acid protein found in most tissues, with high levels in platelets and white blood cells. It binds actin, one of the proteins cells use to move and change shape, which is why scientists have studied it for years in wound healing and tissue repair. The 17–23 region is the part researchers describe as responsible for actin binding and cell migration.
TB-500 first drew attention as a veterinary preparation. Anti-doping laboratories in horse racing identified the acetylated LKKTETQ fragment in TB-500 products and, in 2012, published methods to detect it in horse urine and plasma. That history matters: much of what you read about TB-500 online comes from animal use and marketing, not from human medicine.
What does the research on TB-500 actually show?
Honest answer: it's early. Here's how the evidence breaks down, from strongest to weakest.
Cell and animal studies
Most of the research is on full-length thymosin beta-4. In lab and animal models it has been studied for heart injury, eye injury, skin wounds, and liver and kidney fibrosis, and researchers report effects on new blood vessel growth, inflammation and cell survival.
Small human trials of thymosin beta-4
Early human studies used the full protein, not TB-500: a phase 1 safety study of intravenous thymosin beta-4 in healthy volunteers, and phase 2 eye-drop trials for dry eye. In one 72-person dry-eye trial, the drops didn't beat placebo on either primary endpoint, though some secondary measures improved.
TB-500 itself in people
We found no large, published human trials of the TB-500 fragment for any condition. What it does in people, at what amount, and for how long, hasn't been established.
Weight loss
There's no human evidence that TB-500 causes weight loss. It isn't a GLP-1 medication and doesn't work like one.
So when you see TB-500 described as a recovery or "healing" peptide, read that as a description of what researchers are studying, not a proven benefit. We use the same conservative language with our clients.
Is TB-500 legal? The 2026 HHS policy explained
On October 28, 2026, HHS announced an interim enforcement-discretion policy for 503A compounding with six peptide bulk drug substances, including TB-500 acetate; the notice was published in the Federal Register on October 30, 2026. It means federal regulators don't intend to take enforcement action against a state-licensed pharmacy or licensed physician that compounds TB-500 under the policy's conditions, while FDA works through rulemaking on the list of substances 503A pharmacies may use.
| The policy does | The policy does not |
|---|---|
| Let licensed 503A pharmacies compound TB-500 acetate on a patient-specific prescription | Grant FDA approval, or show TB-500 is safe and effective |
| Require the bulk ingredient to come from an FDA-registered facility with a valid certificate of analysis | Cover 503B outsourcing facilities |
| Require one active ingredient per product | Cover blends, such as BPC-157 with TB-500 |
| Require serious adverse events to be reported to FDA MedWatch, and the label "This is a compounded drug product. Not for resale." | Cover products sold online as chemicals "not for human use" |
Each peptide is covered only in its specified ingredient form and routes of administration, and for TB-500 that means an injection under the skin or into muscle, as your provider prescribes. HHS also says it may revisit the policy, in whole or in part, if a safety signal or product quality issue arises. LegitScript, which certifies Regal, updated its review on November 2, 2026 so that offering these six peptides in line with the policy doesn't by itself block certification.
Free, no-obligation consultation
Curious whether TB-500 fits your plan?
Book a free, no-obligation consultation. Your provider decides whether any peptide makes sense after a medical evaluation.
TB-500 vs BPC-157: what's the difference, and can you combine them?
The two are often mentioned together because both are studied in tissue-repair research. They are different molecules from different sources.
| TB-500 | BPC-157 | |
|---|---|---|
| Origin | Fragment (residues 17–23) of thymosin beta-4 | Synthetic 15-amino-acid peptide based on a sequence from a protein in human gastric juice |
| Size | 7 amino acids | 15 amino acids |
| Form named in the HHS policy | TB-500 acetate | BPC-157 acetate |
| Evidence | Mostly cell and animal research on full thymosin beta-4 | Mostly cell and animal research |
| FDA-approved? | No | No |
| Sport | Prohibited by WADA (S2) | Prohibited by WADA (S0) |
Can you take BPC-157 and TB-500 together?
Pre-mixed "BPC-157/TB-500" blends are outside the HHS policy, which requires a single active ingredient per compounded product. Regal doesn't offer blends or stacks. Whether any one peptide fits you, and whether a second makes sense, is your provider's decision after your evaluation; there are no human studies of the two used together.
TB-500 side effects, and who shouldn't use it
Because TB-500 hasn't been through large human trials, its side-effect profile and long-term safety in people are not well defined. Here's what we tell clients.
- Unknown long-term safety. There's no long-term human data for the fragment.
- Injection-site reactions. Redness, soreness, itching or swelling can happen with any injected product.
- Possible interactions. Little is known, so tell your provider about every medication and supplement you take.
- Cancer history. Thymosin beta-4 is studied for promoting new blood vessel growth and cell migration, and researchers have found higher levels of it in some cancer cells. If you have active cancer or a history of cancer, this needs a careful conversation with your provider, and TB-500 may not be appropriate.
- Pregnancy and breastfeeding. Not used. There is no safety data.
If you have a reaction you're worried about, contact your provider, and seek emergency care for signs of a severe allergic reaction such as swelling of the face or throat or trouble breathing.
Is TB-500 banned in sports? WADA status
Yes. Thymosin beta-4 and its derivatives, with TB-500 named as an example, are listed under S2 (peptide hormones, growth factors, related substances and mimetics) of the World Anti-Doping Agency's Prohibited List, a category banned at all times, in and out of competition. Horse racing laboratories test for it too.
If you compete in a drug-tested sport, check the current list with your sport's governing body or anti-doping organization before considering TB-500. A prescription doesn't change its status in sport.
How Regal prescribes TB-500 in Dallas–Fort Worth
At Regal, TB-500 is never a standalone product. It's an optional add-on for clients in a medically supervised weight loss program, which still centers on a nutrition plan, weekly coaching check-ins and, when clinically appropriate, medication such as a GLP-1.
- Free consultation.Online, by phone or in person at our Mesquite, Fort Worth or Grand Prairie office. Ask anything, including whether a peptide makes sense for you at all.
- Medical evaluation.Eric Naifeh, FNP, PMHNP, DC, our Medical Director, reviews your history, medications and labs. Many clients don't need a peptide, and he'll tell you so.
- A patient-specific prescription.If he decides TB-500 fits, it's single-ingredient TB-500 acetate compounded by a licensed pharmacy for you alone, in the form and route he prescribes, as the policy allows. Your provider explains how you'll receive it.
- Weekly check-ins.Your consultant asks how you're doing every week, and anything unusual goes to your provider. Serious adverse events are reported to FDA MedWatch, as the policy requires.
Prefer a virtual visit? We see clients by video, phone or WhatsApp anywhere in Texas. Compare it with the other peptides on our peptide therapy page, or start with our weight loss programs.
Frequently asked questions
Has the FDA approved TB-500?
No. The FDA has not approved TB-500 for any use. Since October 2026, an HHS enforcement-discretion policy allows licensed 503A pharmacies to compound single-ingredient TB-500 acetate on a patient-specific prescription under set conditions. That is not approval: it doesn't show the peptide is safe or effective, and HHS can revise or withdraw the policy.
Is TB-500 the same as thymosin beta-4?
Not quite. Thymosin beta-4 is a natural 43-amino-acid protein. TB-500 is a synthetic copy of just seven of those amino acids (positions 17–23, LKKTETQ), with an acetyl group added. Most published research, including the small human trials, used the full protein, so results from thymosin beta-4 studies can't simply be assumed for TB-500.
Will TB-500 help me lose weight?
There's no human evidence that it does. TB-500 has been studied for tissue repair, mostly in cells and animals, not for weight loss. At Regal it's only an optional add-on to a program built on a nutrition plan, weekly coaching and, when appropriate, medication such as a GLP-1. Those have far stronger evidence for weight loss.
Can I take BPC-157 and TB-500 together?
Not as a blend. The HHS policy covers only products with one active ingredient, so pre-mixed BPC-157/TB-500 products fall outside it, and Regal doesn't offer blends or stacks. Whether either peptide suits you is your provider's call after a medical evaluation. There are no human studies of the two used together.
How much TB-500 would I take, and for how long?
We don't publish dosing, because there's no established human dose for TB-500 and it isn't a do-it-yourself product. If your provider decides it fits after your evaluation, he sets the prescription for you and your consultant checks in every week. Be cautious of websites that post TB-500 "protocols"; they aren't based on human trials.
Can I get TB-500 through a virtual visit in Texas?
Regal offers free consultations and virtual visits by video, phone or WhatsApp anywhere in Texas, plus in-person visits in Mesquite, Fort Worth and Grand Prairie. TB-500 is prescribed only after a medical evaluation, and only if it's appropriate for you. Your provider explains how you'll receive it.
Sources
- HHS. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. Federal Register, Oct 30, 2026 (91 FR 68526)
- Ho EN et al. Doping control analysis of TB-500, a synthetic version of an active region of thymosin β4, in equine urine and plasma. J Chromatogr A 2012
- Xing Y et al. Progress on the function and application of thymosin β4. Front Endocrinol 2021
- Sosne G, Ousler GW. Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled phase II trial. Clin Ophthalmol 2015
- BakerHostetler. HHS issues enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances (summary of covered forms and routes), 2026





